As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- A social network for cancer patients is helping them connect without fear of friends pitying them for their diagnosison November 19, 2019 at 8:53 am
Fabian Bolin had the idea for the app when he was diagnosed with acute lymphoblastic leukemia in 2015, and realized the impact it had on his mental health.
- Marlton's Roanne Silver Feels Whole After Breast Cancer Surgeryon November 19, 2019 at 5:35 am
“When the radiologist told me ‘you have breast cancer,’ I was panicked,” Roanne said. “I NEVER expected to hear those words, and I immediately feared the worst.” (Virtua Health) In fall 2017, Roanne ...
- Alabama Women with Breast Cancer Lean on Faith for Healingon November 18, 2019 at 4:05 pm
Two Alabama women open up about their breast cancer diagnosis and how their belief in God delivered -- two -- supernatural stories of survival.
- Expert: Herbal aids can slow wound healing in breast cancer spread to skinon November 18, 2019 at 10:20 am
Cardoso presented the observations Thursday at the Advanced Breast Cancer Fifth International Consensus Conference, in Lisbon. Information presented at meetings is considered preliminary until ...
- Facebook relents after breast cancer tattoo artist stages proteston November 18, 2019 at 10:01 am
“It seems like a little thing, but … it matters so much,” triple-negative breast cancer survivor Tamara Fedczak told SurvivorNetin an interview. She underwent several months of chemotherapy and a ...
- Neutrophil-lymphocyte ratio in metastatic breast cancer is not an independent predictor of survival, but depends on other variableson November 18, 2019 at 2:13 am
Breast cancer is still a major cause of cancer mortality in women. Distant metastases, both at diagnosis and as a result of early breast cancer recurrence, cause most of BC deaths. Although recent ...
- Mother and daughter pen children's book about breast canceron November 17, 2019 at 4:41 pm
NEWNAN, Ga. (AP) — When Shaquita Estes was diagnosed with breast cancer, one of the hardest things she said she had to deal with was the loss of her hair from chemotherapy. It was also hard for her to ...
- Greensboro woman struggling with costs after breast cancer diagnosis at 21 years oldon November 15, 2019 at 10:14 am
There's one thing she would have never imagined drawing into her future. She was diagnosed with Stage 1b breast cancer at the age of 21. Stage 1b breast cancer which means small clusters of breast ...
- Mindfulness may ease symptoms of breast canceron November 14, 2019 at 9:45 am
Women with advanced breast cancer might find mindfulness can ease their pain, anxiety and depression, a new study suggests. Mindfulness is the ability to keep your mind focused on the present moment. ...
via Bing News